6 withdrawn. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Withdrawn 6 |
Follow Fibromyalgia: new trials by email Literature Review of Fibromyalgia trials Research Report on Fibromyalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed Duloxetine - Fibromyalgia | Phase 4 | Withdrawn | University of California, San Diego | 2012-06-01 | 2019-08-09 | |
| The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients Milnacipran - Systemic Lupus Erythematosus, Widespread Pain | Phase 4 | Withdrawn | Loma Linda University | 2011-10-01 | 2015-09-18 | |
| Fibromyalgia of Less Than One Year Duration. Study of Pregabalin Pregabalin - Fibromyalgia | Phase 4 | Withdrawn | Newton-Wellesley Hospital | 2011-09-01 | 2014-04-14 | |
| A Study for Adolescents With Fibromyalgia Syndrome Duloxetine - Fibromyalgia | Phase 4 | Withdrawn | Eli Lilly and Company | 2010-03-01 | 2019-11-04 | |
| Calcitonin in the Treatment of Fibromyalgia salmon calcitonin, intranasal saline solution plus glycerol - Fibromyalgia | Phase 4 | Withdrawn | Unidad de Investigacion en Enfermedades Cronico-Degenerativas | 2008-10-01 | 2015-12-04 | |
| Zonisamide for Fibromyalgia & Migraine zonisamide - Fibromyalgia, Migraine | Phase 4 | Withdrawn | University of Pittsburgh | 2004-08-01 | 2011-06-01 |
Pain (2) · Fatigue (1) · Lupus Erythematosus, Systemic (1) · Migraine Disorders (1)
Muscular Diseases (6) · Musculoskeletal Diseases (6) · Nervous System Diseases (6) · Neuromuscular Diseases (6) · Rheumatic Diseases (6) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Connective Tissue Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Immune System Diseases (1)
Duloxetine Hydrochloride (2) · Glycerol (1) · Milnacipran (1) · Pregabalin (1) · Zonisamide (1) · salmon calcitonin (1)
Eli Lilly and Company (1) · Loma Linda University (1) · Newton-Wellesley Hospital (1) · Unidad de Investigacion en Enfermedades Cronico-Degenerativas (1) · University of California, San Diego (1) · University of Pittsburgh (1)
United States (5) · Mexico (1)
Cesar R. Ramos-Remus, M.D., MSc (1) · Dawn Marcus, MD (1) · Don Goldenberg, MD (1) · Emmanuel P. Katsaros, D.O. (1)
PMID 15818684, PMID 18278830, PMID 18400400, PMID 19539427, PMID 20461783, PMID 3553636